UNIZA is a venture of Pashupati Group through which they have forayed into the Pharmaceutical industry. Uniza has carved out a niche of its own in India Business, International Business and Manufacturing of tablets, capsules, creams and ointments. In its India business, the company has a distribution network and presence in 28 states with over 1500 stockists and 150+ brands across four therapies namely Dermatology, Cardio-Diabetic, Gynecology and Respiratory. Since its inception in 2020, Uniza has strategically established its presence in Southeast Asian, African and Latin American Markets and has filed dossiers in over 25 countries, with over 250+ filings and 300+ products developed in its state-of-the-art formulations and development lab. The manufacturing unit of the company has received the following approvals: WHO GMP, Yemen, Tanzania, Ethiopia, Kenya, Uganda, Ghana, Nigeria, Peru, Philippines, Cambodia. Uniza has developed a strong portfolio of products ranging in therapies of Cardiovascular, Anti Epileptic, Antihypertensive, Narcotics, Nephrology, Pain management and Dermatology.